TO: Regulatory Information Service
PR Newswire
RE: CHAPTER 16 PARAGRAPH 13 OF
THE LISTING RULES
Diageo plc (the 'Company') announces:
1) That it received notification on 23 February 2004 for the purposes of
Section 329 of the Companies Act 1985 of transactions by the trustee of the
Diageo Employee Benefit Trust (the 'Employee Benefit Trust') as detailed below.
The Employee Benefit Trust is a discretionary trust for the benefit of
employees of the Company and its subsidiaries and operates primarily in
conjunction with the Company's Long Term Incentive Plan, now called the Total
Shareholder Return plan (the 'Plan'), approved by shareholders on 11 August
1998.
a) A notification that Mourant & Co Trustees Limited, as trustee of the
Employee Benefit Trust ('Mourant'), had, on 20 February 2004, transferred
ordinary shares of 28 101/108 pence of the Company ('Ordinary Shares') to
participants receiving awards released under the Plan at a level of 72.2% as
follows:
Date of Transaction No. of Ordinary Shares
20.02.04 740,775
including Ordinary Shares transferred to the directors of the Company named
below, as participants receiving awards released under the Plan, as follows:
Name of Director No. of Ordinary Shares
N C Rose 71,696
P S Walsh 132,073
The awards were made on 1 January 2001. The balance of each award has lapsed.
b) A notification that Mourant had, on 20 February 2004, made the following
sale of Ordinary Shares to meet the requirement to reimburse the Company for
PAYE tax liability on awards released under the Plan:
Date of Transaction No. of Ordinary Shares Sale Price of
Sold Ordinary
Shares
20.02.04 168,750 £7.195
including Ordinary Shares sold on behalf of a director of the Company, as
follows.
Name of Director No. of Ordinary Shares Sale Price of
Ordinary Shares
N C Rose 28,678 £7.195
P S Walsh 52,829 £7.195
c) A notification that Mourant had, on 20 February 2004, made the following
sale of Ordinary Shares to meet the requirement to reimburse the Company for
National Insurance liabilities on awards released under the Plan:
Date of Transaction No of Ordinary Shares Sale Price of
Sold Ordinary
Shares
20.02.04 4,176 £7.195
including Ordinary Shares sold on behalf of a director of the Company, as
follows.
Name of Director No. of Ordinary Shares Sale Price of
Ordinary Shares
N C Rose 717 £7.195
P S Walsh 1,320 £7.195
d) A notification that Mourant had, on 20 February 2004, purchased 820,000
Ordinary Shares for the Employee Benefit Trust at a price of £7.2724040 per
Ordinary Share. Both directors of the Company named above under a) are
potential beneficiaries of the Employee Benefit Trust.
e) A notification that as a result of the above transactions the total holding
of the Employee Benefit Trust amounts to 6,345,249 Ordinary Shares.
As a result of the above release of awards, sales and acquisition of interests,
the above directors' interests in the Company's Ordinary Shares (excluding
options, awards under the Company's LTIPs and also interests as potential
beneficiaries of the Diageo Employee Benefit Trust and the Grand Metropolitan
No.2 Employee Share Trust) are as follows:
Name of Director No. of Ordinary Shares
N C Rose 169,773
P S Walsh 666,846
23 February 2004
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.